Women's voices in the menopause: Results from an international survey on vaginal atrophy

Rossella E. Nappi, Marta Kokot-Kierepa

Research output: Contribution to journalArticle

Abstract

Objectives: To consider issues relating to vaginal atrophy via an international survey. Methods: Using a structured questionnaire, interviews were performed on 4246 women aged 55-65 years living in Sweden, Finland, the United Kingdom, the United States and Canada. Results: Overall, 98% of survey respondents were postmenopausal. Thirty-nine percent of the postmenopausal women had experienced vaginal atrophy, with the prevalence varying between countries, from 34% in Canada to 43% in Finland and the United States. Attitudes towards symptoms also varied between countries. Symptoms were described as moderate or severe by less than half of women from Finland and Sweden, compared with nearly two-thirds of women from the United States. However, vaginal atrophy was deemed to impact on quality of life by a higher proportion of women in Finland and Sweden (≥60%) than in the United Kingdom, the United States and Canada (≤50%). Overall, 77% of respondents believed women were uncomfortable discussing vaginal atrophy and 42% did not know that local treatment was available. The proportions of women unaware of the availability of local treatment were higher in the United States, the United Kingdom and Canada (51%, 50% and 48%, respectively), and very low in Finland (10%). Whilst 63% of women who had experienced vaginal atrophy had never been prescribed treatment for the condition, 67% of those who had been treated reported positive effects. Conclusion: The survey results illustrate differing needs of menopausal women in different countries. Country-specific approaches may be required to improve the uptake of treatment for vaginal atrophy.

Original languageEnglish
Pages (from-to)233-238
Number of pages6
JournalMaturitas
Volume67
Issue number3
DOIs
Publication statusPublished - Nov 2010

Fingerprint

Menopause
Atrophy
Finland
Canada
Sweden
Availability
Surveys and Questionnaires
Therapeutics
Quality of Life
Interviews

Keywords

  • Attitude
  • Menopause
  • Survey
  • Vaginal atrophy

ASJC Scopus subject areas

  • Obstetrics and Gynaecology
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Women's voices in the menopause : Results from an international survey on vaginal atrophy. / Nappi, Rossella E.; Kokot-Kierepa, Marta.

In: Maturitas, Vol. 67, No. 3, 11.2010, p. 233-238.

Research output: Contribution to journalArticle

@article{248dbc6772274f95aee55a0d332399c0,
title = "Women's voices in the menopause: Results from an international survey on vaginal atrophy",
abstract = "Objectives: To consider issues relating to vaginal atrophy via an international survey. Methods: Using a structured questionnaire, interviews were performed on 4246 women aged 55-65 years living in Sweden, Finland, the United Kingdom, the United States and Canada. Results: Overall, 98{\%} of survey respondents were postmenopausal. Thirty-nine percent of the postmenopausal women had experienced vaginal atrophy, with the prevalence varying between countries, from 34{\%} in Canada to 43{\%} in Finland and the United States. Attitudes towards symptoms also varied between countries. Symptoms were described as moderate or severe by less than half of women from Finland and Sweden, compared with nearly two-thirds of women from the United States. However, vaginal atrophy was deemed to impact on quality of life by a higher proportion of women in Finland and Sweden (≥60{\%}) than in the United Kingdom, the United States and Canada (≤50{\%}). Overall, 77{\%} of respondents believed women were uncomfortable discussing vaginal atrophy and 42{\%} did not know that local treatment was available. The proportions of women unaware of the availability of local treatment were higher in the United States, the United Kingdom and Canada (51{\%}, 50{\%} and 48{\%}, respectively), and very low in Finland (10{\%}). Whilst 63{\%} of women who had experienced vaginal atrophy had never been prescribed treatment for the condition, 67{\%} of those who had been treated reported positive effects. Conclusion: The survey results illustrate differing needs of menopausal women in different countries. Country-specific approaches may be required to improve the uptake of treatment for vaginal atrophy.",
keywords = "Attitude, Menopause, Survey, Vaginal atrophy",
author = "Nappi, {Rossella E.} and Marta Kokot-Kierepa",
year = "2010",
month = "11",
doi = "10.1016/j.maturitas.2010.08.001",
language = "English",
volume = "67",
pages = "233--238",
journal = "Maturitas",
issn = "0378-5122",
publisher = "Elsevier Ireland Ltd",
number = "3",

}

TY - JOUR

T1 - Women's voices in the menopause

T2 - Results from an international survey on vaginal atrophy

AU - Nappi, Rossella E.

AU - Kokot-Kierepa, Marta

PY - 2010/11

Y1 - 2010/11

N2 - Objectives: To consider issues relating to vaginal atrophy via an international survey. Methods: Using a structured questionnaire, interviews were performed on 4246 women aged 55-65 years living in Sweden, Finland, the United Kingdom, the United States and Canada. Results: Overall, 98% of survey respondents were postmenopausal. Thirty-nine percent of the postmenopausal women had experienced vaginal atrophy, with the prevalence varying between countries, from 34% in Canada to 43% in Finland and the United States. Attitudes towards symptoms also varied between countries. Symptoms were described as moderate or severe by less than half of women from Finland and Sweden, compared with nearly two-thirds of women from the United States. However, vaginal atrophy was deemed to impact on quality of life by a higher proportion of women in Finland and Sweden (≥60%) than in the United Kingdom, the United States and Canada (≤50%). Overall, 77% of respondents believed women were uncomfortable discussing vaginal atrophy and 42% did not know that local treatment was available. The proportions of women unaware of the availability of local treatment were higher in the United States, the United Kingdom and Canada (51%, 50% and 48%, respectively), and very low in Finland (10%). Whilst 63% of women who had experienced vaginal atrophy had never been prescribed treatment for the condition, 67% of those who had been treated reported positive effects. Conclusion: The survey results illustrate differing needs of menopausal women in different countries. Country-specific approaches may be required to improve the uptake of treatment for vaginal atrophy.

AB - Objectives: To consider issues relating to vaginal atrophy via an international survey. Methods: Using a structured questionnaire, interviews were performed on 4246 women aged 55-65 years living in Sweden, Finland, the United Kingdom, the United States and Canada. Results: Overall, 98% of survey respondents were postmenopausal. Thirty-nine percent of the postmenopausal women had experienced vaginal atrophy, with the prevalence varying between countries, from 34% in Canada to 43% in Finland and the United States. Attitudes towards symptoms also varied between countries. Symptoms were described as moderate or severe by less than half of women from Finland and Sweden, compared with nearly two-thirds of women from the United States. However, vaginal atrophy was deemed to impact on quality of life by a higher proportion of women in Finland and Sweden (≥60%) than in the United Kingdom, the United States and Canada (≤50%). Overall, 77% of respondents believed women were uncomfortable discussing vaginal atrophy and 42% did not know that local treatment was available. The proportions of women unaware of the availability of local treatment were higher in the United States, the United Kingdom and Canada (51%, 50% and 48%, respectively), and very low in Finland (10%). Whilst 63% of women who had experienced vaginal atrophy had never been prescribed treatment for the condition, 67% of those who had been treated reported positive effects. Conclusion: The survey results illustrate differing needs of menopausal women in different countries. Country-specific approaches may be required to improve the uptake of treatment for vaginal atrophy.

KW - Attitude

KW - Menopause

KW - Survey

KW - Vaginal atrophy

UR - http://www.scopus.com/inward/record.url?scp=77958113067&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77958113067&partnerID=8YFLogxK

U2 - 10.1016/j.maturitas.2010.08.001

DO - 10.1016/j.maturitas.2010.08.001

M3 - Article

C2 - 20828948

AN - SCOPUS:77958113067

VL - 67

SP - 233

EP - 238

JO - Maturitas

JF - Maturitas

SN - 0378-5122

IS - 3

ER -